HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 730.45
-14.80 (-1.99%)
Aug 20, 2026, 3:30 PM IST
NSE:HCG Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹800.60. The average 1-year stock price forecast is 9.60% higher than the current stock price, while the lowest is ₹724.00 (-0.88%) and the highest is ₹920.00 (+25.95%).
Price Target: ₹800.60 (+9.60%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 7 | 8 | 9 | 9 | 9 |
| Buy | 3 | 0 | 0 | 0 | 0 | 1 |
| Hold | 1 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst ICICI Securities No rating | ICICI Securities | Buy Maintains ₹710.00 | Buy | Maintains | ₹710.00 | -2.80% | Feb 27, 2026 |
| Geojit Research | Geojit Research | Buy Upgrades ₹724.00 | Buy | Upgrades | ₹724.00 | -0.88% | Feb 19, 2026 |
Financial Forecast
Revenue This Year
29.01B
from 25.45B
Increased by 13.96%
Revenue Next Year
33.33B
from 29.01B
Increased by 14.89%
EPS This Year
9.27
from 3.59
Increased by 157.99%
EPS Next Year
14.85
from 9.27
Increased by 60.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.